S 320 – New York

Status: In Process
Year Introduced: 2021
Link: https://www.nysenate.gov/legislation/bills/2021/S320

Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing. The added section empowers the superintendent to investigate any increase in a “critical prescription drug” as defined in the amendment that exceeds
the consumer list price index during any preceding twelve month period.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found